Barbara Seaman book – tracks the well-intentioned discovery of synthetic estrogen through the unconscionable and misleading promotion of a dangerous drug: DES
Exploding the Estrogen Myth
With the ardent tone of a close friend, Barbara Seaman draws on forty years of journalistic research to expose the “menopause industry” and shows how estrogen therapy often causes more problems—including breast cancer, heart attack, and stroke—than it cures. The Greatest Experiment Ever Performed on Women tracks the well-intentioned discovery of synthetic estrogen through the unconscionable and misleading promotion of a dangerous drug.
Barbara Seaman’s groundbreaking book traces the history of estrogen use from its early purveyors, including a well-meaning British doctor who lost control of the marketing of DES and therefore inadvertently led to the DES baby crisis, to Nazi experimentation with women and estrogen, to the present, and looks at how an experiment of this proportion could have been conducted without oversight, intervention, or real knowledge as to what its effects would be.
Barbara Seaman turns up essential, often shocking, information that should have been part of public awareness but, only now, is coming to light.
How BigPharma brainwashes Americans into believing they’re sick
Most of us have our guard up when it comes to direct-to-consumer drug advertising. We know the butterflies, sunsets and puppies in the TV ads are designed to distract us from terms like “blood clot,” “heart attack,” “stroke,” “seizure,” “life-threatening allergic reaction” and “death.” We are aware that more than half the ads tell us why we don’t actually want to ask our doctor about the new wonder drug.
Unbranded advertising, however, is much more insidious. Instead of selling a drug, it sells the disease driving the drug sales and sometimes doesn’t mention the drug at all.
Dépistage systématique par
mammographie, rapport du 15 décembre 2013
Some 5,400 women contract breast cancer in Switzerland every year, and around 1,400 die of this disease annually. “Systematic mammography screening” is the term used to describe the serial radiological examination of women within the framework of a screening program. Thereby all women in a specific age group are invited to an X-ray examination of their breasts which is not conducted by a doctor. In some Cantons, such screening programs are offered to all women aged from 50 to 69.
In the present report by the Swiss Medical Board, the issue is addressed of whether, by using systematic mammography screening, tumors can be detected at an earlier stage, so that the survival time with good quality of life of the affected women can be prolonged, and, in the final analysis, the mortality rate from breast cancer can be reduced. The potentially negative effects of the screenings (such as excess therapy or psychological stress in the event of false positive examination results) are assessed, as well as the costs-effectiveness ratio.
On the basis of the existing literature, the conclusion can be drawn that systematic mammography screening can contribute to the discovery of tumors at an earlier stage. The mortality rate from breast cancer can be reduced slightly by means of the screening: According to study data from the years 1963 to 1991, of 1,000 women with regular screening, 1 to 2 fewer women die from breast cancer than 1,000 without regular screening. This desirable effect is offset by the undesirable effects: Specifically, with about 100 of 1,000 women with screening, erroneous undesirable effects: Specifically, with about 100 of 1,000 women with screening, erroneous treatments. Furthermore, the costs-effectiveness ratio is very unfavorable.
The findings from the present investigation lead to the following recommendations:
It is not recommended that systematic mammography screening programs be introduced.
A time limit is to be set on existing systematic mammography screening programs.
All forms of mammography screening are to be evaluated with regard to quality.
Likewise, for all forms of mammography screening, a previous thorough medical evaluation and a comprehensible clarification with presentation of the desirable and undesirable effects are recommended.
” I couldn’t let October’s Breast Cancer Awareness (but not prevention) Month come to a close without posting a satire cartoon exposing all the pinkwashing we’ve seen that month. You can buy everything in pink these days, from bottled water to fried chicken, alcohol and even handguns. So why not cigarettes? All these pink products claim to give some mystery percentage of “net profits” (which could be zero if the company isn’t profitable) to “find a cure for cancer” (a ridiculous proposition since we already have natural cures for cancer).
It’s all part of the cancer industry’s brainwashing propaganda that tries to convince people that we can cure cancer by going shopping! ”
Help Cancer Research UK Beat Cancer Sooner through a Space Game
If you have ever wanted to help cure cancer, you might now be able to do so – with a spot of space-travel from the comfort of your own home. Scientists at Cancer Research UK have developed an intergalactic smartphone game to help them analyse the overwhelming reams of genetic data generated in recent studies. They hope thousands of people will play the game, simultaneously trawling through genetic material to pinpoint more precisely which genes cause the disease.
Play to CureGenes in Space is a new pioneering mobile phone game from Cancer Research UK, which lets players unravel real cancer data through a space game. What would have taken scientists hours to analyse, can now be done faster with your help and the collective force of thousands of players. Watch this to find out more about the game and see real game play.
In Utero Exposure to EDCs increases EZH2 Expression in the Mammary Gland
Breast cancer risk has both heritable and environment/lifestyle components. The heritable component is a small contribution (5-27 %), leaving the majority of risk to environment (e.g., applied chemicals, food residues, occupational hazards, pharmaceuticals, stress) and lifestyle (e.g., physical activity, cosmetics, water source, alcohol, smoking). However, these factors are not well-defined, primarily due to the enormous number of factors to be considered. In both humans and rodent models, environmental factors that act as endocrine disrupting compounds (EDCs) have been shown to disrupt normal mammary development and lead to adverse lifelong consequences, especially when exposures occur during early life. EDCs can act directly or indirectly on mammary tissue to increase sensitivity to chemical carcinogens or enhance development of hyperplasia, beaded ducts, or tumors. Protective effects have also been reported. The mechanisms for these changes are not well understood. Environmental agents may also act as carcinogens in adult rodent models, directly causing or promoting tumor development, typically in more than one organ. Many of the environmental agents that act as EDCs and are known to affect the breast are discussed. Understanding the mechanism(s) of action for these compounds will be critical to prevent their effects on the breast in the future.
NCBI, PMID: 23417729 PubMedPMCID: PMC3682794 2013 Mar
The Full Study, J Mammary Gland Biol Neoplasia. Author manuscript; available in PMC 2013 June 14., PMCID: PMC3682794 NIHMSID: NIHMS468165 Endocrine Disruptors and the Breast: Early Life Effects and Later Life Disease includes:
Chemical Carcinogenesis and Endocrine Disruptors
Mammary Gland Development and Correlation to Cancer
Une conférence-débat sur les victimes d’effets indésirables graves de médicaments et la façon de se faire reconnaître et de s’en sortir a été organisée par la revue Prescrire lors de la cérémonie de la Pilule d’Or Prescrire, à Paris, le 30 janvier 2014. Réunissant des participants d’origines très diverses, il a été souligné qu’il est nécessaire de sortir du déni sociétal pour mieux soigner.